Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a 5-year survival rate of <8% [...].
MeSH terms
-
Carcinoma, Pancreatic Ductal* / drug therapy
-
Humans
-
Pancreatic Ducts / pathology
-
Pancreatic Neoplasms* / drug therapy
-
Survival Rate
Grants and funding
D.D.C. was supported by Fondazione Umberto Veronesi (FUV) and Fondazione Italiana per la ricerca sulle Malattie del Pancreas (FIMP).